Immune System Diseases
Praxis Dr. Jürgen Schmidt conducts research on Herpes Zoster vaccination, assessing long‑term efficacy, safety, and the persistence of the immune response in older adults.
- Evaluation of vaccine efficacy in preventing shingles
- Assessment of safety profiles for senior populations
- Study of immune response durability over time
- Exploration of preventive strategies for viral‑induced immune disorders
The site’s expertise in immunology supports the development of vaccines that protect against immune‑mediated viral diseases.
Respiratory Tract Diseases
Research at the center includes an Respiratory Syncytial Virus vaccine program that measures the humoral immune response after single revaccination doses given in seasonal windows for adults aged 60 and above.
- Timing of revaccination in pre‑season periods
- Safety monitoring in elderly participants
- Analysis of antibody levels post‑vaccination
- Impact of seasonal administration on disease prevention
These studies aim to reduce the burden of RSV‑related respiratory illness in the senior community.
Virus Diseases
The site advances viral vaccine research by evaluating both shingles and RSV immunizations, focusing on overall effectiveness and long‑term protection in adult populations.
- Cross‑protective benefits of viral vaccines
- Durability of immune responses across different viruses
- Adult immunization strategies for viral infections
- Potential public‑health impact of widespread vaccine use
Collaborative efforts with European health agencies enhance the translation of trial findings into broader preventive health measures.
